Clinical and diagnostic findings in 20 patients with toxoplasmosis and the Acquired Immune Deficiency Syndrome

References

1. Ruskin J, Remington JS. Toxoplasmosis in the compromised host. Ann Intern Med 1976; 84:193–199
   [Google Scholar]
2. Carter AO, Frank JW. Congenital toxoplasmosis: epidemiologic features and control. Can Med Assoc J 1986; 135:618–623
   [Google Scholar]
3. Wreghitt TG, Hakim M, Gray JJ. et al. Toxoplasmosis in heart and heart and lung transplant recipients. J Clin Pathol 1989; 42:194–199
   [Google Scholar]
4. Luft BJ, Remington JS. Toxoplasmic encephalitis. J Infect Dis 1988; 157:1–6
   [Google Scholar]
5. Gransden WR, Brown PM. Pneumocystic pneumonia and disseminated toxoplasmosis in a male homosexual. Br Med J 1983; 286:1614
   [Google Scholar]
6. Sabin AB, Feldman HA. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoon parasite (Toxoplasma). Science 1948; 108:660–663
   [Google Scholar]
7. Holliman RE, Johnson J, Duffy K, New L. Discrepant toxoplasma latex agglutination test results. J Clin Pathol 1989; 42:200–203
   [Google Scholar]
8. Payne RA, Joynson DHM, Balfour AH. et al. Public Health Laboratory Service enzyme linked immunosorbent assay for detecting Toxoplasma specific IgM antibody. J Clin Pathol 1987; 40:276–281
   [Google Scholar]
9. Duffy KT, Wharton PJ, Johnson JD, New L, Holliman RE. Assessment of an immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM. J Clin Pathol 1989; 42:1291–1295
   [Google Scholar]
10. Savva D, Morris JC, Johnson JD, Holliman RE. Polymerase chain reaction for detection of Toxoplasma gondii. J Med Microbiol 1990; 32:25–31
    [Google Scholar]
11. Hughes HPA, Hudson L, Fleck DG. In vitro culture of Toxoplasma gondii m primary and established cell lines. Int J Parasitol 1986; 16:317–322
    [Google Scholar]
12. Holliman RE. Toxoplasmosis and the acquired immune deficiency syndrome. J Infect 1988; 16:121–128
    [Google Scholar]
13. Naot Y, Luft BJ, Remington JS. False-positive serological tests in heart transplant recipients. Lancet 1981; 2:590–591
    [Google Scholar]
14. The TE Study Group Haverkos HW. Assessment of therapy for toxoplasma encephalitis. Am J Med 1987; 82:907–914
    [Google Scholar]
15. Elkin CM, Leon E, Grenell SL, Leeds NE. Intracranial lesions in the acquired immunodeficiency syndrome. JAMA 1985; 253:393–396
    [Google Scholar]
16. Potsman I, Resnick L, Luft BJ, Remington JS. Intrathecal production of antibodies against Toxoplasma gondii in patients with toxoplasmic encephalitis and the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1988; 108:49–51
    [Google Scholar]
17. Navia BA, Petito CK, Gold JW, Cho ES, Jordan BD, Price RW. Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients. Ann Neurol 1986; 19:224–238
    [Google Scholar]
18. Holliman RE, Johnson JD. The post-natal serodiagnosis of congenital toxoplasmosis. Serodiag Immunother 1989; 3:323–327
    [Google Scholar]